Strong international performance for Gpi in Q3 2024, with new international contracts totalling € 8.8 million, marking an 18% increase compared to Q2.
Among the key successes, the software division secured over € 6.7 million in contracts, driven by the advanced Gpi4Med Suite. This reflects the strategic focus on high-margin, innovative products. The Group also recorded strong demand for its clinical record solutions, particularly those supporting disability care.
Riedl, the pharmacy automation robot, also performed well, generating € 2.1 million in contracts and strengthening Gpi’s presence with significant deals in Europe, Jordan, Greece, Japan, and Ivory Coast.
Read the press release
